Safety, Tolerability and PK of AZD1152 in Patients With Relapsed Acute Myeloid Leukaemia (AML)

Mise à jour : Il y a 5 ans
Référence : NCT00530699

Femme et Homme

  • | Pays :
  • Japan
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The purpose of this study is to assess safety and tolerability of multiple ascending doses of AZD1152 and to assess effect of AZD1152 on the rate of complete remission in patients with relapsed acute myeloid leukaemia who are not considered to be suitable for standard chemotherapy.


Critère d'inclusion

  • Acute myeloid leukaemia

Liens